Cargando…

Immune classification of osteosarcoma

Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSO...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Trang, Su, Sumeyye, Shahriyari, Leili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992873/
https://www.ncbi.nlm.nih.gov/pubmed/33757216
http://dx.doi.org/10.3934/mbe.2021098
_version_ 1783669469193699328
author Le, Trang
Su, Sumeyye
Shahriyari, Leili
author_facet Le, Trang
Su, Sumeyye
Shahriyari, Leili
author_sort Le, Trang
collection PubMed
description Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSORTx, to obtain the relative abundance of 22 immune cells. Then we cluster patients based on their estimated immune abundance and study the characteristics of these clusters, along with the relationship between immune infiltration and outcome of patients. We find that abundance of CD8 T cells, NK cells and M1 Macrophages have a positive association with prognosis, while abundance of γδ T cells, Mast cells, M0 Macrophages and Dendritic cells have a negative association with prognosis. Accordingly, the cluster with the lowest proportion of CD8 T cells, M1 Macrophages and highest proportion of M0 Macrophages has the worst outcome among clusters. By grouping patients with similar immune patterns, we are also able to suggest treatments that are specific to the tumor microenvironment.
format Online
Article
Text
id pubmed-7992873
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-79928732021-03-25 Immune classification of osteosarcoma Le, Trang Su, Sumeyye Shahriyari, Leili Math Biosci Eng Article Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSORTx, to obtain the relative abundance of 22 immune cells. Then we cluster patients based on their estimated immune abundance and study the characteristics of these clusters, along with the relationship between immune infiltration and outcome of patients. We find that abundance of CD8 T cells, NK cells and M1 Macrophages have a positive association with prognosis, while abundance of γδ T cells, Mast cells, M0 Macrophages and Dendritic cells have a negative association with prognosis. Accordingly, the cluster with the lowest proportion of CD8 T cells, M1 Macrophages and highest proportion of M0 Macrophages has the worst outcome among clusters. By grouping patients with similar immune patterns, we are also able to suggest treatments that are specific to the tumor microenvironment. 2021-02-22 /pmc/articles/PMC7992873/ /pubmed/33757216 http://dx.doi.org/10.3934/mbe.2021098 Text en This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
spellingShingle Article
Le, Trang
Su, Sumeyye
Shahriyari, Leili
Immune classification of osteosarcoma
title Immune classification of osteosarcoma
title_full Immune classification of osteosarcoma
title_fullStr Immune classification of osteosarcoma
title_full_unstemmed Immune classification of osteosarcoma
title_short Immune classification of osteosarcoma
title_sort immune classification of osteosarcoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992873/
https://www.ncbi.nlm.nih.gov/pubmed/33757216
http://dx.doi.org/10.3934/mbe.2021098
work_keys_str_mv AT letrang immuneclassificationofosteosarcoma
AT susumeyye immuneclassificationofosteosarcoma
AT shahriyarileili immuneclassificationofosteosarcoma